Making Medicines Affordable

Making Medicines Affordable Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Making Medicines Affordable book. This book definitely worth reading, it is an incredibly well-written.

Making Medicines Affordable

National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Making Medicines Affordable Book PDF

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Publisher : National Academies Press
Page : 235 pages
File Size : 45,7 Mb
Release : 2018-03-01
Category : Medical
ISBN : 9780309468084

Get Book

Making Medicines Affordable by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies Pdf

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Making Medicines Affordable

National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Making Medicines Affordable Book PDF

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Publisher : National Academies Press
Page : 235 pages
File Size : 43,9 Mb
Release : 2018-04-01
Category : Medical
ISBN : 9780309468053

Get Book

Making Medicines Affordable by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies Pdf

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Making Medicines Affordable

Ranjit Roy Chaudhury,Nirmal Kumar Gurbani
Making Medicines Affordable Book PDF

Author : Ranjit Roy Chaudhury,Nirmal Kumar Gurbani
Publisher : Anshan Pub
Page : 0 pages
File Size : 43,9 Mb
Release : 2005
Category : Consumer cooperatives
ISBN : 1904798268

Get Book

Making Medicines Affordable by Ranjit Roy Chaudhury,Nirmal Kumar Gurbani Pdf

"At a time when governments are trying to reduce escalating expenditures on medicines in their health care systems or are trying to increase access to quality medicines for their people, this book provides some experiences gained in this field"--Page 4 of cover.

Equitable Access to High-Cost Pharmaceuticals

Zaheer-Ud-Din Babar
Equitable Access to High Cost Pharmaceuticals Book PDF

Author : Zaheer-Ud-Din Babar
Publisher : Academic Press
Page : 238 pages
File Size : 44,5 Mb
Release : 2018-02-27
Category : Business & Economics
ISBN : 9780128119624

Get Book

Equitable Access to High-Cost Pharmaceuticals by Zaheer-Ud-Din Babar Pdf

Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs Incorporates existing guidelines and recommendations by international organizations Compares and contrasts how different countries fund and police high-cost drug access Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing Reviews novel pharmaceuticals of current research interest

Prescription for the People

Fran Quigley
Prescription for the People Book PDF

Author : Fran Quigley
Publisher : ILR Press
Page : 0 pages
File Size : 44,7 Mb
Release : 2017
Category : Business & Economics
ISBN : 1501713752

Get Book

Prescription for the People by Fran Quigley Pdf

Cover -- Contents -- Acknowledgments -- Introduction -- Part I. Toxic Impacts -- 1. People Everywhere Are Struggling to Get the Medicines They Need -- 2. The United States Has a Drug Problem -- 3. Millions of People Are Dying Needlessly -- 4. Cancer Patients Face Particularly Deadly Barriers to Medicines -- 5. The Current Medicine System Neglects Many Major Diseases -- Part II. Profits over Patients -- 6. Corporate Research and Development Investments Are Exaggerated -- 7. The Current System Wastes Billions on Drug Marketing -- 8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior -- 9. Medicines Are Priced at Whatever the Market Will Bear -- 10. Pharmaceutical Corporations Reap History-Making Profits -- Part III. Patently Poisonous -- 11. The For-Profit Medicine Arguments Are Patently False -- 12. Medicine Patents Are Extended Too Far and Too Wide -- 13. Patent Protectionism Stunts the Development of New Medicines -- 14. Governments, Not Private Corporations, Drive Medicine Innovation -- 15. Taxpayers and Patients Pay Twice for Patented Medicines -- Part IV. Trading Away Our Health -- 16. Medicines Are a Public Good -- 17. Medicine Patents Are Artificial, Recent, and Government-Created -- 18. The United States and Big Pharma Play the Bully in Extending Patents -- 19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments -- Part V.A Better Remedy -- 20. Current Law Provides Opportunities for Affordable Generic Medicines -- 21. There Is a Better Way to Develop Medicines -- 22. Human Rights Law Demands Access to Essential Medicines -- Conclusion -- Notes -- Index

The Great American Drug Deal

Peter Kolchinsky
The Great American Drug Deal Book PDF

Author : Peter Kolchinsky
Publisher : Evelexa Press
Page : 278 pages
File Size : 46,6 Mb
Release : 2020-01-20
Category : Business & Economics
ISBN : 1733058915

Get Book

The Great American Drug Deal by Peter Kolchinsky Pdf

Do we really have to choose between affordability of drugs and lifesaving innovation? No. In The Great American Drug Deal, Peter Kolchinsky offers clear-eyed analysis, compelling stories, and vital ideas for closing loopholes, dealing with bad actors, supporting patients, and fueling discoveries that ease suffering now and for generations to come.

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access

National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Health Care Services
The Role of NIH in Drug Development Innovation and Its Impact on Patient Access Book PDF

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Health Care Services
Publisher : National Academies Press
Page : 103 pages
File Size : 51,9 Mb
Release : 2020-01-27
Category : Medical
ISBN : 9780309498517

Get Book

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Health Care Services Pdf

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.

WHO guideline on country pharmaceutical pricing policies

Anonim
WHO guideline on country pharmaceutical pricing policies Book PDF

Author : Anonim
Publisher : World Health Organization
Page : 70 pages
File Size : 53,5 Mb
Release : 2020-09-29
Category : Business & Economics
ISBN : 9789240011878

Get Book

WHO guideline on country pharmaceutical pricing policies by Anonim Pdf

In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.

Medicine Price Surveys, Analyses and Comparisons

Sabine Vogler
Medicine Price Surveys Analyses and Comparisons Book PDF

Author : Sabine Vogler
Publisher : Academic Press
Page : 488 pages
File Size : 45,5 Mb
Release : 2018-10-23
Category : Business & Economics
ISBN : 9780128132128

Get Book

Medicine Price Surveys, Analyses and Comparisons by Sabine Vogler Pdf

Medicine Price Surveys, Analyses and Comparisons establishes guidelines for the study and implementation of pharmaceutical price surveys, analyses, and comparisons. Its contributors evaluate price survey literature, discuss the accessibility and reliability of data sources, and provide a checklist and training kit on conducting price surveys, analyses, and comparisons. Their investigations survey price studies while accounting for the effects of methodologies and explaining regional differences in medicine prices. They also consider policy objectives such as affordable access to medicines and cost-containment as well as options for improving the effectiveness of policies. Provides guidance for planning and implementing pharmaceutical pricing policies and systems Reviews external price referencing systems Explains common baselines for interpreting price surveys Defines pharmaceutical price terminology and nomenclature

Bottle of Lies

Katherine Eban
Bottle of Lies Book PDF

Author : Katherine Eban
Publisher : HarperCollins
Page : 512 pages
File Size : 54,5 Mb
Release : 2020-06-23
Category : Medical
ISBN : 9780063054103

Get Book

Bottle of Lies by Katherine Eban Pdf

A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.

Delivering Affordable Cancer Care in the 21st Century

Institute of Medicine,Board on Health Care Services,National Cancer Policy Forum
Delivering Affordable Cancer Care in the 21st Century Book PDF

Author : Institute of Medicine,Board on Health Care Services,National Cancer Policy Forum
Publisher : National Academies Press
Page : 95 pages
File Size : 54,6 Mb
Release : 2013-06-20
Category : Medical
ISBN : 9780309269445

Get Book

Delivering Affordable Cancer Care in the 21st Century by Institute of Medicine,Board on Health Care Services,National Cancer Policy Forum Pdf

Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness.In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop.

The Future of Nursing

Institute of Medicine,Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine
The Future of Nursing Book PDF

Author : Institute of Medicine,Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine
Publisher : National Academies Press
Page : 700 pages
File Size : 45,9 Mb
Release : 2011-02-08
Category : Medical
ISBN : 9780309208956

Get Book

The Future of Nursing by Institute of Medicine,Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine Pdf

The Future of Nursing explores how nurses' roles, responsibilities, and education should change significantly to meet the increased demand for care that will be created by health care reform and to advance improvements in America's increasingly complex health system. At more than 3 million in number, nurses make up the single largest segment of the health care work force. They also spend the greatest amount of time in delivering patient care as a profession. Nurses therefore have valuable insights and unique abilities to contribute as partners with other health care professionals in improving the quality and safety of care as envisioned in the Affordable Care Act (ACA) enacted this year. Nurses should be fully engaged with other health professionals and assume leadership roles in redesigning care in the United States. To ensure its members are well-prepared, the profession should institute residency training for nurses, increase the percentage of nurses who attain a bachelor's degree to 80 percent by 2020, and double the number who pursue doctorates. Furthermore, regulatory and institutional obstacles-including limits on nurses' scope of practice-should be removed so that the health system can reap the full benefit of nurses' training, skills, and knowledge in patient care. In this book, the Institute of Medicine makes recommendations for an action-oriented blueprint for the future of nursing.

Drugs, Money, and Secret Handshakes

Robin Feldman
Drugs Money and Secret Handshakes Book PDF

Author : Robin Feldman
Publisher : Cambridge University Press
Page : 203 pages
File Size : 44,9 Mb
Release : 2023-10-31
Category : Law
ISBN : 9781009432948

Get Book

Drugs, Money, and Secret Handshakes by Robin Feldman Pdf

Examines the pharmaceutical industry to expose how higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines.

A Practical Approach to Pharmaceutical Policy

Andreas Seiter
A Practical Approach to Pharmaceutical Policy Book PDF

Author : Andreas Seiter
Publisher : World Bank Publications
Page : 238 pages
File Size : 52,6 Mb
Release : 2010-06-17
Category : Medical
ISBN : 0821383876

Get Book

A Practical Approach to Pharmaceutical Policy by Andreas Seiter Pdf

This book offers policy makers a hands-on approach, tested in the World Bank’s field work in many countries, for developing policies that improve access to safe, effective medicines in health systems of low- and middle-income economies.

Intellectual Property and Public Health in the Developing World

Monirul Azam
Intellectual Property and Public Health in the Developing World Book PDF

Author : Monirul Azam
Publisher : Open Book Publishers
Page : 348 pages
File Size : 50,6 Mb
Release : 2016-05-30
Category : Law
ISBN : 9781783742318

Get Book

Intellectual Property and Public Health in the Developing World by Monirul Azam Pdf

Across the world, developing countries are attempting to balance the international standards of intellectual property concerning pharmaceutical patents against the urgent need for accessible and affordable medicines. In this timely and necessary book, Monirul Azam examines the attempts of several developing countries to walk this fine line. He evaluates the experiences of Brazil, China, India, and South Africa for lessons to guide Bangladesh and developing nations everywhere. Azam's legal expertise, concern for public welfare, and compelling grasp of principal case studies make Intellectual Property and Public Health in the Developing World a definitive work. The developing world is striving to meet the requirements of the World Trade Organization's TRIPS Agreement on intellectual property. This book sets out with lucidity and insight the background of the TRIPS Agreement and its implications for pharmaceutical patents, the consequences for developing countries, and the efforts of certain representative nations to comply with international stipulations while still maintaining local industry and public health. Azam then brings the weight of this research to bear on the particular case of Bangladesh, offering a number of specific policy recommendations for the Bangladeshi government—and for governments the world over. Intellectual Property and Public Health in the Developing World is a must-read for public policy-makers, academics and students, non-governmental organizations, and readers everywhere who are interested in making sure that developing nations meet the health care needs of their people.